These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development. Nierenberg AA; Kansky C; Brennan BP; Shelton RC; Perlis R; Iosifescu DV Aust N Z J Psychiatry; 2013 Jan; 47(1):26-42. PubMed ID: 22711881 [TBL] [Abstract][Full Text] [Related]
9. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. Andreazza AC; Wang JF; Salmasi F; Shao L; Young LT J Neurochem; 2013 Nov; 127(4):552-61. PubMed ID: 23692477 [TBL] [Abstract][Full Text] [Related]
10. Cellular models to study bipolar disorder: A systematic review. Viswanath B; Jose SP; Squassina A; Thirthalli J; Purushottam M; Mukherjee O; Vladimirov V; Patrinos GP; Del Zompo M; Jain S J Affect Disord; 2015 Sep; 184():36-50. PubMed ID: 26070045 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy. Callaly E; Walder K; Morris G; Maes M; Debnath M; Berk M Mini Rev Med Chem; 2015; 15(5):355-65. PubMed ID: 25807948 [TBL] [Abstract][Full Text] [Related]
13. Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond. Kato T Schizophr Res; 2017 Sep; 187():62-66. PubMed ID: 27839913 [TBL] [Abstract][Full Text] [Related]
14. A model of the mitochondrial basis of bipolar disorder. Morris G; Walder K; McGee SL; Dean OM; Tye SJ; Maes M; Berk M Neurosci Biobehav Rev; 2017 Mar; 74(Pt A):1-20. PubMed ID: 28093238 [TBL] [Abstract][Full Text] [Related]
15. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Iwamoto K; Bundo M; Kato T Hum Mol Genet; 2005 Jan; 14(2):241-53. PubMed ID: 15563509 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. Gubert C; Stertz L; Pfaffenseller B; Panizzutti BS; Rezin GT; Massuda R; Streck EL; Gama CS; Kapczinski F; Kunz M J Psychiatr Res; 2013 Oct; 47(10):1396-402. PubMed ID: 23870796 [TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Clay HB; Sillivan S; Konradi C Int J Dev Neurosci; 2011 May; 29(3):311-24. PubMed ID: 20833242 [TBL] [Abstract][Full Text] [Related]
18. The role of mitochondrial dysfunction in bipolar disorder. Kato T Drug News Perspect; 2006 Dec; 19(10):597-602. PubMed ID: 17299601 [TBL] [Abstract][Full Text] [Related]
19. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes. Valvassori SS; Bavaresco DV; Feier G; Cechinel-Recco K; Steckert AV; Varela RB; Borges C; Carvalho-Silva M; Gomes LM; Streck EL; Quevedo J Psychiatry Res; 2018 Jun; 264():192-201. PubMed ID: 29653348 [TBL] [Abstract][Full Text] [Related]
20. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]